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ABSTRACT 
A New RP-HPLC technique was development and validation of effective and economical tool for quantitative 
estimation of Naproxen in dosage forms rapid, reproducible and selective reverse phase HPLC method has been 
developed for the estimation of  Naproxen in dosage form.It was resolved by using a mobile phase of Potassium 
dihydrogen phosphate: methanol in the ratio 30:70 v/v  at a flow rate of 0.8 ml/min. on  HPLC system using UV 
- Visible detector at the wavelength of  287 nm. The column used was C18 (4.6 x 150mm, 3 mm, Make: 
Zorbax) .The linearity range was found to be 10-50 µg/ml. The proposed new method is found to be economic, 
sensitive, precise, rapid and reproducible. 
Keywords:, Naproxen, RP-HPLC, new method development, validation 
 
Intoduction 
Naproxen is a proprionic acid derivative related to the arylacetic acid group of nonsteroidal anti-inflammatory 
drugs
1,2
. Naproxen has a molecular weight of 230.26 and a molecular formula of C14H14O3.It is lipid ¬soluble, 
practically insoluble in water at low pH and freely soluble in water at high pH. The octanol/water partition 
coefficient of naproxen at pH 7.4 is 1.6 to 1.8 The chemical name for naproxen
3,4
, USP is (S)-6-methoxy-α-
methyl-2-naphthaleneacetic acid. It has the following structural formula show in fig 1:- 
 
 
Fig.1: Chemical structure of Naproxen 
These drugs are used for the management of mild to moderate pain, fever, and inflammation. They 
work by reducing the levels of prostaglandins, chemicals that are responsible for pain, fever, and inflammation. 
Naproxen blocks the enzyme that makes prostaglandins (cyclooxygenase), resulting in lower concentrations of 
prostaglandins. Naproxen has analgesic and antipyretic properties
5,6,7
. As with other NSAIDs, its mode of action 
is not fully understood; however, its ability to inhibit prostaglandin synthesis may be involved in the anti-
inflammatory effect. The mechanism of action of naproxen, like that of other NSAIDs, is believed to be 
associated with the inhibition of cyclooxygenase activity. Two unique cyclooxygenases have been described in 
mammals
8
. The constitutive cyclooxygenase, COX-1, synthesizes prostaglandins necessary for normal 
gastrointestinal and renal function
9,10
. The inducible cyclooxygenase, COX-2, generates prostaglandins involved 
in inflammation
11
. Inhibition of COX-1 is thought to be associated with gastrointestinal and renal toxicity while 
inhibition of COX-2 provides anti-inflammatory activity
12,13,14
.  
 
MATERIALS AND METHODS 
1. Reagents and Standard – Naproxen tablets 
a. Water HPLC Grade. 
b. Naproxen  Working Standard. 
c.  Methanol 
d. Sodium hydroxide 
  
2 Chromatographic Parameters 
Equipment             : High performance liquid chromatography equipped with    
      Auto Sampler and DAD or UV detector. 
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Column                         :Symmetry C18 (4.6 x 150mm, 3 mm, Make: Zorbax)                              Flow rate 
 : 0.8mL per min 
Wavelength  : 287 nm 
Injection volume : 20 ml 
Column oven   : Ambient 
Run time   : 6.0 min 
 
3. Preparation of Sodium Phosphate buffer: 
Weigh 2.5milli grams of sodium di hydrogen phosphate into a 1000ml beaker, dissolve and diluted to 1000ml 
with HPLC water. Adjusted the pH to 7.0 with Sodium hydroxide 
Preparation of mobile phase 
Mix a mixture of above buffer 300mL (30%) and 700 mL of Methanol HPLC (70%) and degas in ultrasonic 
water bath for 5 minutes. Filter through 0.45 µ filter under vacuum filtration. 
 
4.  Diluent Preparation: Mobile phase as diluent 
 
5. Preparation of the Naproxen Standard & Sample Solution: 
5.1 Standard Solution Preparation: 
Accurately weigh and transfer 10mg of Naproxen Working standard into a 10 mL  volumetric  flask add about 7 
mL of Diluent and sonicate to dissolve it completely and make volume up to the mark with the same solvent. 
(Stock solution) Further pipette 0.4 ml of the above stock solution into a 10ml volumetric flask and dilute up     
to the mark with diluent. Mix well and filter through 0.45µm filter. 
 
5.2 Sample Solution Preparation: 
Weigh 5 Naproxen Tablets and calculate the average weight. Accurately weigh and transfer the sample 
equivalent to 10 mg of Naproxen into a 10 mL volumetric flask. Add about 7 mL of diluent and sonicate to 
dissolve it completely and make volume up to the mark with diluent. Mix well and filter through 0.45µm filter. 
Further pipette0.4 ml of the above stock solution into a 10ml volumetric flask and dilute up to the mark with 
diluent. Mix well and filter through 0.45µm filter. 
 
6. System Suitability: 
Tailing factor for the peak due to Naproxen in Standard solution should not be more Than 2.0 
Theoretical plates for the Naproxen peak in Standard solution should not less than  2000 
 
7. System Suitability Results: 
1). Tailing factor Obtained from the standard injection is 1.5 
2). Theoretical Plates Obtained from the standard injection is 4324.4 
 
8. Assay Results: 
Weight of 5 tablets:   0.5510  grams 
Average Weight     : 0.1030grams 
 
1867403         10          0. 4          10        10      99.8      325 
 -------------- x ----------x --------- x ----------x------x------X 100 = 99.4% 
1875180       10           10          13    0. 4        100     250 
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METHOD VALIDATION SUMMARY: 
9.1    Precision:  
The standard solution was injected for five times and measured the area for all five injections in HPLC. The %RSD for 
the area of five replicate injections was found to be within the specified limits. 
The results are summarized  
Injection Area 
Injection-1 1871423 
Injection-2 1876279 
Injection-3 1874529 
Injection-4 1879273 
Injection-5 1873436 
Average 1874987.9 
Standard Deviation 2973.1 
%RSD 0.2 
 
Acceptance Criteria: 
The % RSD for the area of Five standard injections results should not be more than 2%. 
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9.2 Intermediate Precision:  
To evaluate the intermediate precision (also known as Ruggedness) of the method, Precision was performed on 
different day by using different make column of same dimensions. 
The standard solution was injected for Five times and measured the area for all five injections in HPLC. 
The %RSD for the area of five replicate injections was found to be within the specified limits 
The results are summarized in  
Injection Area 
Injection-1 1869365 
Injection-2 1868938 
Injection-3 1861814 
Injection-4 1867522 
Injection-5 1866552 
Average 1866837.9 
Standard Deviation 3023.9 
%RSD 0.2 
 
Acceptance Criteria: 
The % RSD for the area of Five standard injections results should not be more than 2%. 
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10. Accuracy:  
Inject the standard solution, Accuracy -50%, Accuracy -100% and Accuracy -150% solutions.Calculate the Amount 
found and Amount added for Naproxen and calculate the individual recovery and mean recovery values. 
The results are summarized  
%Concentration 
(at specification 
Level) 
Area 
Amount 
Added 
(mg) 
Amount 
Found 
(mg) 
% Recovery 
Mean 
Recovery 
50% 2006872 5.0 5.0 100.0% 
     100.5% 100% 4014113 10.0       10.0 100.0% 
150% 6104804 15.0 15.2 101.4% 
 
Acceptance Criteria: 
The % Recovery for each level should be between 98.0 to 102.0%. 
 
11. LINEARITY:1  
Preparation of stock solution: Accurately weigh and transfer 10mg of Naproxen API sample into a 10 mL 
volumetric flask add about 7 mL of Diluent and sonicate to dissolve it completely and make volume up to the 
mark  
with the same solvent. (Stock solution) 
Preparation of Level – I (20µg/ml):  
0.2ml of stock solution has taken in 10 ml of volumetric flask dilute up to the mark with diluent 
Preparation of Level – I (30µg/ml):  
0.3ml of stock solution has taken in 10 ml of volumetric flask dilute up to the mark with diluent.  
Preparation of Level – II (40µg/ml):  
0.4ml of stock solution taken in 10 ml of volumetric flask dilute up to the mark with diluent.  
Preparation of Level – III (50µg/ml):  
0.5ml of stock solution taken in 10 ml of volumetric flask dilute up to the mark with diluent.  
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Preparation of Level – IV (60µg/ml):  
0.6ml of stock solution taken in 10 ml of volumetric flask dilute up to the mark with diluent.  
Procedure:  
Inject each level into the chromatographic system and measure the peak area. Plot a graph of peak area versus 
concentration (on X-axis concentration and on Y-axis Peak area) and calculate the correlation coefficient. 
Linearity Results: 
S.No Linearity Level Concentration Area 
1 I 20µg/ml 1121401 
2 II 30µg/ml 1529276 
3 III 40µg/ml 1879755 
4 IV 50µg/ml 2344717 
5 V 60µg/ml 2766815 
Correlation Coefficient 0.999 
 
Acceptance Criteria: 
Correlation coefficient should be not less than 0.999. 
 
 
12.  LIMIT OF DETECTION: 
Average Baseline Noise obtained from Blank :    51µV 
Signal Obtained from LOD solution (0.25% of target assay concentration)  :   152 µV 
S/N =        152/51=   2.98 
Acceptance Criteria: 
S/N Ratio value shall be 3 for LOD solution. 
 
13. LIMIT OF QUANTIFICATION: 
Average Baseline Noise obtained from Blank :    51µV 
Signal Obtained from LOQ solution (0.75% of target assay concentration) :    509 µV 
S/N =        509/51 =   9.98 
Acceptance Criteria: 
S/N Ratio value shall be 10 for LOQ solution. 
 
14. ROBUSTNESS: 
As part of the Robustness, deliberate change in the Flow rate, Mobile Phase composition, Temperature 
Variation was made to evaluate the impact on the method. 
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S.No 
 
Flow Rate (ml/min) 
System Suitability Results 
USP Plate Count USP Tailing 
 0.7             4486                1.5 
 0.8               4324.4           1.5 
     0.9        4306         1.4 
Results for actual flow (0.8 ml/min) have been considered from Assay standard. 
 
b). The Organic composition in the Mobile phase was varied from70% to 50%. 
S.No 
Change in Organic 
Composition in the 
Mobile Phase  
System Suitability Results 
USP Plate Count USP Tailing 
         10% less                4758                1.5 
 *Actual   4324.4        1.5 
 10% more        3807        1.5 
Results for actual Mobile phase composition (70:30Methanol: Buffer) have been considered From 
Assay standard 
 
RESULT AND DISCUSSION 
A New simple, precision and accuracy HPLC method was developed the estimation of Naproxen analysis , 
consisting of an Acetonitrile: buffer system (60: 40 % v/v). The chromatographic condition was set at a low rate 
of 0.8 ml/min with the UV detector at 230 nm. The above method was optimized with a view to develop an assay 
method for Naproxen.Several mobile phase compositions were tried to resolve the peaks of  Naproxen. The 
optimum mobile phase containing  KH2PO4 buffer : methanol (30;70 % v/v) was selected because it was found 
ideal to resolve the analytic peaks of  the drugs
15,16
. Quantification was achieved with UV detections at 287 nm 
based on peak area and absorbence. As per USP requirements system suitability studies were carried out and 
freshly prepared standard solutions are Naproxen
17,18
 . Various parameters obtained with 20 µl of injection 
volume are summarized in the table given below.Validation and system suitability parameters 
Table:5 
S.NO PARAMETERS LIMIT OBSERVATION 
1 
System suitability (%RSD 
of tailing factor) 
suitable 
 
1.5 
2. Specificity No interferences Specific  
3 
Precision: 
A)System Precision 
B).Method precision 
RSD NMT 2.0% 
RSD NMT 2.0% 
0.2 
0.2 
4 Linearity Correlation coefficient NLT 0.999 1.000 
5 Accuracy %Recovery range98-102 % 100.5 
6 Robustness RSD NMT  2% Robustted 
7 LOD S:N Ratio should be    more than 3:1 
2.98 
 
8 LOQ S:N ratio should be    more than 10:1 9.98  
The system is suitable for tailing factor, theoretical plate, resolution. The data obtained from the 
precision experiments. The R.S.D. value for precision was indication that the method was efficiently 
precise.Percentage recovery was calculated from 80% to 120% by injecting to HPLC. The excellent recovery 
was made at each added concentration.  There is allowable variation in flow rate, wave length which indicates 
that method is robust enough.The LOD for  Naproxen were found to be 2.98 µg/ml The LOQ for  Naproxen 
were found to be 9.98µg/ml  The chromatogram of sample showed a single peak at the retention time of  
Naproxen indicating that there is no interference of the changing the persons for injecting the sample to the 
instrument. 
 
CONCLUSION 
The reliability and suitability of the method could be seen from recovery studies. Further there is no interference 
due to excipients . System suitability parameters were calculated which includes efficiency, resolution and 
tailing factor. Precision of the methods were studied by making repeated injections of the samples and system 
precision values were determined. The method was validated for linearity, accuracy, precision, robustness. The 
method is new  simple, specific & easy to perform and requires short to analyse the samples. Low limit of 
Quantification and limit of detection makes this method suitable for Quality control. This new  method enables 
Simultaneous determination of  because of good separation and Resolution of the Chromatographic Peaks.The 
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method was found to be accurate, precise and robusted.Hence it was concluded that the RP-HPLC method 
developed was very much suit for routine analysis.Naproxen in tablet formulations and future planings use this 
method for estimation of Naproxen in clinical trials. 
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